Annual Net Income
-$82.67 M
-$67.81 M-456.34%
December 31, 2023
Summary
- As of February 25, 2025, ANIK annual net profit is -$82.67 million, with the most recent change of -$67.81 million (-456.34%) on December 31, 2023.
- During the last 3 years, ANIK annual net income has fallen by -$58.69 million (-244.70%).
- ANIK annual net income is now -315.73% below its all-time high of $38.32 million, reached on December 31, 2014.
Performance
ANIK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$29.92 M
-$29.83 M-33897.73%
September 30, 2024
Summary
- As of February 25, 2025, ANIK quarterly net profit is -$29.92 million, with the most recent change of -$29.83 million (-33897.73%) on September 30, 2024.
- Over the past year, ANIK quarterly net income has stayed the same.
- ANIK quarterly net income is now -299.05% below its all-time high of $15.03 million, reached on March 31, 2014.
Performance
ANIK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$97.52 M
-$23.34 M-31.47%
September 30, 2024
Summary
- As of February 25, 2025, ANIK TTM net profit is -$97.52 million, with the most recent change of -$23.34 million (-31.47%) on September 30, 2024.
- Over the past year, ANIK TTM net income has stayed the same.
- ANIK TTM net income is now -354.49% below its all-time high of $38.32 million, reached on December 31, 2014.
Performance
ANIK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ANIK Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -456.3% | 0.0% | 0.0% |
| 3 y3 years | -244.7% | -5461.6% | -1602.2% |
| 5 y5 years | -541.5% | -425.2% | -458.6% |
ANIK Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2099.7% | at low | <-9999.0% | +52.5% | -2459.0% | at low |
| 5 y | 5-year | -404.0% | at low | -558.1% | +52.5% | -442.4% | at low |
| alltime | all time | -315.7% | at low | -299.1% | +52.5% | -354.5% | at low |
Anika Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.92 M(>+9900.0%) | -$97.52 M(+31.5%) |
| Jun 2024 | - | -$88.00 K(-98.1%) | -$74.18 M(-3.5%) |
| Mar 2024 | - | -$4.51 M(-92.8%) | -$76.83 M(-7.1%) |
| Dec 2023 | -$82.67 M(+456.3%) | -$63.00 M(+858.0%) | -$82.67 M(+236.4%) |
| Sep 2023 | - | -$6.58 M(+139.9%) | -$24.57 M(+10.8%) |
| Jun 2023 | - | -$2.74 M(-73.5%) | -$22.17 M(-0.5%) |
| Mar 2023 | - | -$10.35 M(+110.9%) | -$22.28 M(+49.9%) |
| Dec 2022 | -$14.86 M(-459.4%) | -$4.91 M(+17.6%) | -$14.86 M(-5.6%) |
| Sep 2022 | - | -$4.17 M(+46.9%) | -$15.74 M(+43.0%) |
| Jun 2022 | - | -$2.84 M(-3.1%) | -$11.01 M(+572.6%) |
| Mar 2022 | - | -$2.93 M(-49.4%) | -$1.64 M(-139.6%) |
| Dec 2021 | $4.13 M(-117.2%) | -$5.79 M(-1138.2%) | $4.13 M(-172.2%) |
| Sep 2021 | - | $558.00 K(-91.5%) | -$5.73 M(-54.9%) |
| Jun 2021 | - | $6.53 M(+130.1%) | -$12.70 M(-52.9%) |
| Mar 2021 | - | $2.84 M(-118.1%) | -$26.94 M(+12.3%) |
| Dec 2020 | -$23.98 M(-188.2%) | -$15.66 M(+144.2%) | -$23.98 M(+461.0%) |
| Sep 2020 | - | -$6.41 M(-16.8%) | -$4.28 M(-137.7%) |
| Jun 2020 | - | -$7.71 M(-233.1%) | $11.34 M(-60.2%) |
| Mar 2020 | - | $5.79 M(+43.0%) | $28.48 M(+4.7%) |
| Dec 2019 | $27.19 M(+45.2%) | $4.05 M(-56.0%) | $27.19 M(-11.9%) |
| Sep 2019 | - | $9.20 M(-2.5%) | $30.86 M(+5.5%) |
| Jun 2019 | - | $9.44 M(+109.3%) | $29.26 M(-2.2%) |
| Mar 2019 | - | $4.51 M(-41.6%) | $29.92 M(+59.8%) |
| Dec 2018 | $18.72 M(-41.2%) | $7.72 M(+1.6%) | $18.72 M(-1.8%) |
| Sep 2018 | - | $7.60 M(-24.7%) | $19.07 M(+3.9%) |
| Jun 2018 | - | $10.09 M(-250.9%) | $18.36 M(-6.5%) |
| Mar 2018 | - | -$6.69 M(-182.9%) | $19.64 M(-38.3%) |
| Dec 2017 | $31.82 M(-2.2%) | $8.07 M(+17.1%) | $31.82 M(-0.1%) |
| Sep 2017 | - | $6.89 M(-39.4%) | $31.83 M(-6.1%) |
| Jun 2017 | - | $11.37 M(+107.0%) | $33.90 M(+8.8%) |
| Mar 2017 | - | $5.49 M(-32.1%) | $31.14 M(-4.3%) |
| Dec 2016 | $32.55 M(+5.8%) | $8.09 M(-9.7%) | $32.55 M(-8.3%) |
| Sep 2016 | - | $8.95 M(+3.9%) | $35.51 M(+1.6%) |
| Jun 2016 | - | $8.62 M(+24.9%) | $34.93 M(+2.3%) |
| Mar 2016 | - | $6.89 M(-37.6%) | $34.14 M(+11.0%) |
| Dec 2015 | $30.76 M(-19.7%) | $11.04 M(+31.8%) | $30.76 M(+11.7%) |
| Sep 2015 | - | $8.38 M(+7.2%) | $27.53 M(+8.7%) |
| Jun 2015 | - | $7.82 M(+122.4%) | $25.32 M(-5.5%) |
| Mar 2015 | - | $3.52 M(-55.0%) | $26.80 M(-30.0%) |
| Dec 2014 | $38.32 M(+86.2%) | $7.82 M(+26.7%) | $38.32 M(+3.1%) |
| Sep 2014 | - | $6.17 M(-33.7%) | $37.16 M(+3.4%) |
| Jun 2014 | - | $9.30 M(-38.1%) | $35.94 M(+10.5%) |
| Mar 2014 | - | $15.03 M(+125.9%) | $32.54 M(+58.1%) |
| Dec 2013 | $20.57 M(+75.0%) | $6.65 M(+34.2%) | $20.57 M(+11.9%) |
| Sep 2013 | - | $4.96 M(-15.9%) | $18.38 M(+22.0%) |
| Jun 2013 | - | $5.89 M(+92.1%) | $15.07 M(+16.7%) |
| Mar 2013 | - | $3.07 M(-31.3%) | $12.91 M(+9.8%) |
| Dec 2012 | $11.76 M(+38.9%) | $4.46 M(+171.3%) | $11.76 M(+15.5%) |
| Sep 2012 | - | $1.65 M(-56.0%) | $10.18 M(-11.6%) |
| Jun 2012 | - | $3.74 M(+95.4%) | $11.51 M(+14.5%) |
| Mar 2012 | - | $1.91 M(-33.7%) | $10.05 M(+18.8%) |
| Dec 2011 | $8.47 M(+96.2%) | $2.88 M(-3.1%) | $8.47 M(+22.1%) |
| Sep 2011 | - | $2.98 M(+30.4%) | $6.93 M(+34.9%) |
| Jun 2011 | - | $2.28 M(+603.6%) | $5.14 M(+31.0%) |
| Mar 2011 | - | $324.40 K(-76.0%) | $3.93 M(-9.0%) |
| Dec 2010 | $4.32 M(+17.0%) | $1.35 M(+14.1%) | $4.32 M(+17.8%) |
| Sep 2010 | - | $1.18 M(+11.0%) | $3.66 M(-8.2%) |
| Jun 2010 | - | $1.07 M(+49.3%) | $3.99 M(+2.9%) |
| Mar 2010 | - | $714.30 K(+2.5%) | $3.88 M(+5.2%) |
| Dec 2009 | $3.69 M(+1.6%) | $697.10 K(-53.9%) | $3.69 M(-9.7%) |
| Sep 2009 | - | $1.51 M(+58.2%) | $4.08 M(+11.1%) |
| Jun 2009 | - | $955.80 K(+82.9%) | $3.68 M(+4.0%) |
| Mar 2009 | - | $522.70 K(-52.2%) | $3.53 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | $3.63 M(-39.9%) | $1.09 M(-0.9%) | $3.63 M(-13.8%) |
| Sep 2008 | - | $1.10 M(+35.8%) | $4.21 M(-14.1%) |
| Jun 2008 | - | $812.90 K(+31.6%) | $4.90 M(-10.1%) |
| Mar 2008 | - | $617.60 K(-63.1%) | $5.45 M(-9.7%) |
| Dec 2007 | $6.04 M(+31.1%) | $1.67 M(-6.8%) | $6.04 M(+11.6%) |
| Sep 2007 | - | $1.80 M(+31.6%) | $5.41 M(+9.6%) |
| Jun 2007 | - | $1.36 M(+13.7%) | $4.94 M(+0.3%) |
| Mar 2007 | - | $1.20 M(+14.7%) | $4.92 M(+7.0%) |
| Dec 2006 | $4.60 M(-21.9%) | $1.05 M(-21.0%) | $4.60 M(+5.1%) |
| Sep 2006 | - | $1.32 M(-2.0%) | $4.38 M(-21.6%) |
| Jun 2006 | - | $1.35 M(+53.5%) | $5.59 M(+0.3%) |
| Mar 2006 | - | $880.70 K(+7.1%) | $5.57 M(-5.5%) |
| Dec 2005 | $5.89 M(-47.3%) | $822.30 K(-67.5%) | $5.89 M(-13.7%) |
| Sep 2005 | - | $2.53 M(+89.4%) | $6.83 M(+31.8%) |
| Jun 2005 | - | $1.34 M(+11.2%) | $5.18 M(+12.4%) |
| Mar 2005 | - | $1.20 M(-31.5%) | $4.61 M(-58.8%) |
| Dec 2004 | $11.19 M(+1253.1%) | $1.75 M(+98.5%) | $11.19 M(+9.3%) |
| Sep 2004 | - | $884.00 K(+15.6%) | $10.24 M(+4.7%) |
| Jun 2004 | - | $765.00 K(-90.2%) | $9.77 M(+9.5%) |
| Mar 2004 | - | $7.79 M(+872.0%) | $8.93 M(+979.3%) |
| Dec 2003 | $827.00 K(-127.2%) | $801.00 K(+90.7%) | $827.00 K(-3.3%) |
| Sep 2003 | - | $420.00 K(-618.5%) | $855.00 K(-280.8%) |
| Jun 2003 | - | -$81.00 K(-74.1%) | -$473.00 K(-69.5%) |
| Mar 2003 | - | -$313.00 K(-137.8%) | -$1.55 M(-49.0%) |
| Dec 2002 | -$3.04 M(-55.0%) | $829.00 K(-191.3%) | -$3.04 M(-29.7%) |
| Sep 2002 | - | -$908.00 K(-21.5%) | -$4.33 M(-8.9%) |
| Jun 2002 | - | -$1.16 M(-35.9%) | -$4.75 M(-23.9%) |
| Mar 2002 | - | -$1.80 M(+295.0%) | -$6.24 M(-7.6%) |
| Dec 2001 | -$6.76 M(-3992.6%) | -$456.80 K(-65.7%) | -$6.76 M(+70.6%) |
| Sep 2001 | - | -$1.33 M(-49.7%) | -$3.96 M(-1.3%) |
| Jun 2001 | - | -$2.65 M(+14.3%) | -$4.01 M(+153.8%) |
| Mar 2001 | - | -$2.32 M(-199.1%) | -$1.58 M(-1010.5%) |
| Dec 2000 | $173.60 K(-107.3%) | $2.34 M(-269.1%) | $173.60 K(-103.2%) |
| Sep 2000 | - | -$1.38 M(+532.9%) | -$5.34 M(+34.9%) |
| Jun 2000 | - | -$218.50 K(-61.3%) | -$3.96 M(+18.5%) |
| Mar 2000 | - | -$564.10 K(-82.2%) | -$3.34 M(+34.9%) |
| Dec 1999 | -$2.38 M(-162.5%) | -$3.18 M(-894.2%) | -$2.48 M(-254.8%) |
| Jun 1999 | - | $400.00 K(+33.3%) | $1.60 M(-52.9%) |
| Mar 1999 | - | $300.00 K(+50.0%) | $3.40 M(-8.1%) |
| Dec 1998 | $3.80 M(+15.2%) | $200.00 K(-71.4%) | $3.70 M(-43.1%) |
| Sep 1998 | - | $700.00 K(-68.2%) | $6.50 M(+18.2%) |
| Jun 1998 | - | $2.20 M(+266.7%) | $5.50 M(+52.8%) |
| Mar 1998 | - | $600.00 K(-80.0%) | $3.60 M(+12.5%) |
| Dec 1997 | $3.30 M(-222.2%) | $3.00 M(-1100.0%) | $3.20 M(-557.1%) |
| Sep 1997 | - | -$300.00 K(-200.0%) | -$700.00 K(-46.2%) |
| Jun 1997 | - | $300.00 K(+50.0%) | -$1.30 M(-40.9%) |
| Mar 1997 | - | $200.00 K(-122.2%) | -$2.20 M(-33.3%) |
| Dec 1996 | -$2.70 M(-3.6%) | - | - |
| Nov 1996 | - | -$900.00 K(0.0%) | -$3.30 M(+13.8%) |
| Aug 1996 | - | -$900.00 K(+50.0%) | -$2.90 M(0.0%) |
| Aug 1996 | -$2.80 M(+40.0%) | - | - |
| May 1996 | - | -$600.00 K(-33.3%) | -$2.90 M(+3.6%) |
| Feb 1996 | - | -$900.00 K(+80.0%) | -$2.80 M(+33.3%) |
| Nov 1995 | - | -$500.00 K(-44.4%) | -$2.10 M(+5.0%) |
| Aug 1995 | -$2.00 M(+42.9%) | -$900.00 K(+80.0%) | -$2.00 M(+25.0%) |
| May 1995 | - | -$500.00 K(+150.0%) | -$1.60 M(0.0%) |
| Feb 1995 | - | -$200.00 K(-50.0%) | -$1.60 M(0.0%) |
| Nov 1994 | - | -$400.00 K(-20.0%) | -$1.60 M(+23.1%) |
| Aug 1994 | -$1.40 M(-12.5%) | -$500.00 K(0.0%) | -$1.30 M(0.0%) |
| May 1994 | - | -$500.00 K(+150.0%) | -$1.30 M(+8.3%) |
| Feb 1994 | - | -$200.00 K(+100.0%) | -$1.20 M(+20.0%) |
| Nov 1993 | - | -$100.00 K(-80.0%) | -$1.00 M(+11.1%) |
| Aug 1993 | -$1.60 M | -$500.00 K(+25.0%) | -$900.00 K(+125.0%) |
| May 1993 | - | -$400.00 K | -$400.00 K |
FAQ
- What is Anika Therapeutics annual net profit?
- What is the all time high annual net income for Anika Therapeutics?
- What is Anika Therapeutics annual net income year-on-year change?
- What is Anika Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Anika Therapeutics?
- What is Anika Therapeutics quarterly net income year-on-year change?
- What is Anika Therapeutics TTM net profit?
- What is the all time high TTM net income for Anika Therapeutics?
- What is Anika Therapeutics TTM net income year-on-year change?
What is Anika Therapeutics annual net profit?
The current annual net income of ANIK is -$82.67 M
What is the all time high annual net income for Anika Therapeutics?
Anika Therapeutics all-time high annual net profit is $38.32 M
What is Anika Therapeutics annual net income year-on-year change?
Over the past year, ANIK annual net profit has changed by -$67.81 M (-456.34%)
What is Anika Therapeutics quarterly net profit?
The current quarterly net income of ANIK is -$29.92 M
What is the all time high quarterly net income for Anika Therapeutics?
Anika Therapeutics all-time high quarterly net profit is $15.03 M
What is Anika Therapeutics quarterly net income year-on-year change?
Over the past year, ANIK quarterly net profit has changed by $0.00 (0.00%)
What is Anika Therapeutics TTM net profit?
The current TTM net income of ANIK is -$97.52 M
What is the all time high TTM net income for Anika Therapeutics?
Anika Therapeutics all-time high TTM net profit is $38.32 M
What is Anika Therapeutics TTM net income year-on-year change?
Over the past year, ANIK TTM net profit has changed by $0.00 (0.00%)